Luminary Therapeutic is a cancer research center that develops pre-clinical stage cell therapy for cancer and autoimmune diseases.
Luminary Therapeutics has raised $5.8M in total funding. The most recent round was Grant. The last funding was announced in March 2025.
Luminary Therapeutics's investors include Advanced Research Projects Agency for Health, ScaleReady.
Luminary Therapeutics is headquartered in Minneapolis, United States.
Luminary Therapeutic is a cancer research center that develops pre-clinical stage cell therapy for cancer and autoimmune diseases.
Luminary Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Luminary Therapeutics — Funding & Investors." VCBacked, March 11, 2025, https://www.vcbacked.co/company/luminary-therapeutics. Accessed August 14, 2026.
VCBacked. (2025). Luminary Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/luminary-therapeutics
{{cite web |title=Luminary Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/luminary-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated